Influence of Butyrate on Impaired Gene Expression in Colon from Patients with High Blood Pressure
暂无分享,去创建一个
C. Pepine | M. Raizada | C. Forsmark | E. Handberg | E. Richards | Jing Li | Eyad Alakrad
[1] S. Juraschek,et al. Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial , 2022, Journal of the American Heart Association.
[2] Zhongli Wang,et al. PPARG Silencing Improves Blood Pressure Control and Alleviates Renal Damage by Modulating RAS Circadian Rhythm in Hypertensive Rats. , 2022, Annals of Clinical and Laboratory Science.
[3] C. Pepine,et al. Gut Microbiome and Neuroinflammation in Hypertension , 2022, Circulation research.
[4] K. He,et al. The miR-182/Myadm axis regulates hypoxia-induced pulmonary hypertension by balancing the BMP- and TGF-β-signalling pathways in an SMC/EC-crosstalk-associated manner , 2021, Basic Research in Cardiology.
[5] Wei Hu,et al. Probiotic yogurt blunts the increase of blood pressure in spontaneously hypertensive rats via remodeling of the gut microbiota. , 2021, Food & function.
[6] C. Pepine,et al. Distinct Gene Expression Profiles in Colonic Organoids from Normotensive and the Spontaneously Hypertensive Rats , 2021, Cells.
[7] D. Jin,et al. Key Enzymes for the Mevalonate Pathway in the Cardiovascular System. , 2021, Journal of cardiovascular pharmacology.
[8] C. Pepine,et al. Butyrate Regulates COVID-19-Relevant Genes in Gut Epithelial Organoids From Normotensive Rats. , 2020, Hypertension.
[9] Joshua F. McMichael,et al. Integration of the Drug–Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts , 2020, bioRxiv.
[10] M. Raizada,et al. Gut–brain–bone marrow axis in hypertension , 2020, Current opinion in nephrology and hypertension.
[11] I. Kema,et al. Different tryptophan-kynurenine metabolism profiles in human pulmonary arterial hypertension and animal models of pulmonary hypertension , 2020 .
[12] J. P. Rigalli,et al. Acute regulation of apical ABC transporters in the gut. Potential influence on drug bioavailability. , 2020, Pharmacological research.
[13] M. Raizada,et al. SARS-CoV-2 Receptor ACE-2 (Angiotensin-Converting Enzyme 2) Is Upregulated in Colonic Organoids From Hypertensive Rats , 2020, Hypertension.
[14] E. Elinav,et al. Interaction between microbiota and immunity in health and disease , 2020, Cell Research.
[15] T. Spector,et al. Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease , 2020, Circulation.
[16] C. Pepine,et al. Transcriptomic Signature of Gut Microbiome-Contacting Cells in Colon of Spontaneously Hypertensive Rats. , 2019, Physiological genomics.
[17] C. Sigmund,et al. PPARγ and RhoBTB1 in hypertension. , 2019, Current opinion in nephrology and hypertension.
[18] F. Jouret,et al. Gut Microbiota and Fecal Levels of Short-Chain Fatty Acids Differ Upon 24-Hour Blood Pressure Levels in Men. , 2019, Hypertension.
[19] Hong Li,et al. Calcium-Activated Chloride Channel A4 (CLCA4) Plays Inhibitory Roles in Invasion and Migration Through Suppressing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Colorectal Cancer , 2019, Medical science monitor : international medical journal of experimental and clinical research.
[20] J. Duarte,et al. Critical Role of the Interaction Gut Microbiota – Sympathetic Nervous System in the Regulation of Blood Pressure , 2019, Front. Physiol..
[21] M. Grandoch,et al. Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage , 2018, Circulation.
[22] J. Sierra,et al. Higher Fecal Short-Chain Fatty Acid Levels Are Associated with Gut Microbiome Dysbiosis, Obesity, Hypertension and Cardiometabolic Disease Risk Factors , 2018, Nutrients.
[23] Eun Woo Son,et al. iDEP: an integrated web application for differential expression and pathway analysis of RNA-Seq data , 2018, BMC Bioinformatics.
[24] C. Shively,et al. Comparative Microbiome Signatures and Short-Chain Fatty Acids in Mouse, Rat, Non-human Primate, and Human Feces , 2018, Front. Microbiol..
[25] James A. Hutchinson,et al. Novel molecules mediate specialized functions of human regulatory macrophages , 2018, Current opinion in organ transplantation.
[26] C. Pepine,et al. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. , 2018, Clinical science.
[27] C. Pepine,et al. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression , 2017, Gut.
[28] C. Gieger,et al. Transcriptome-Wide Analysis Identifies Novel Associations With Blood Pressure , 2017, Hypertension.
[29] F. Perez-Vizcaino,et al. Antihypertensive Effects of Probiotics , 2017, Current Hypertension Reports.
[30] Weili Zhang,et al. Gut microbiota dysbiosis contributes to the development of hypertension , 2017, Microbiome.
[31] C. Pepine,et al. Hypertension-Linked Pathophysiological Alterations in the Gut , 2017, Circulation research.
[32] E. Boerwinkle,et al. Genome-Wide and Gene-Based Meta-Analyses Identify Novel Loci Influencing Blood Pressure Response to Hydrochlorothiazide , 2017, Hypertension.
[33] David S. Wishart,et al. Heatmapper: web-enabled heat mapping for all , 2016, Nucleic Acids Res..
[34] C. Pepine,et al. Brain-Gut-Bone Marrow Axis: Implications for Hypertension and Related Therapeutics. , 2016, Circulation research.
[35] S. Najjar,et al. High-fat diet amplifies renal renin angiotensin system expression, blood pressure elevation, and renal dysfunction caused by Ceacam1 null deletion. , 2015, American journal of physiology. Endocrinology and metabolism.
[36] C. Pepine,et al. Gut Dysbiosis Is Linked to Hypertension , 2015, Hypertension.
[37] S. Akira,et al. IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity , 2015, Cell Death and Disease.
[38] Young-Joon Kim,et al. Oligoadenylate synthase-like (OASL) proteins: dual functions and associations with diseases , 2015, Experimental & Molecular Medicine.
[39] Andrew D. Johnson,et al. A Meta-analysis of Gene Expression Signatures of Blood Pressure and Hypertension , 2015, PLoS genetics.
[40] Anders K. Haakonsson,et al. PPARγ and the global map of adipogenesis and beyond , 2014, Trends in Endocrinology & Metabolism.
[41] W. Xia,et al. Slc26a3 deficiency is associated with loss of colonic HCO3− secretion, absence of a firm mucus layer and barrier impairment in mice , 2014, Acta physiologica.
[42] D. Hassett,et al. Loss of NHE3 alters gut microbiota composition and influences Bacteroides thetaiotaomicron growth. , 2013, American journal of physiology. Gastrointestinal and liver physiology.
[43] Barbara M. Bakker,et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism , 2013, Journal of Lipid Research.
[44] J. M. Suh,et al. PPARγ signaling and metabolism: the good, the bad and the future , 2013, Nature Medicine.
[45] A. Ridley,et al. MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression , 2013, Molecular biology of the cell.
[46] J. Gordon,et al. Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation , 2013, Proceedings of the National Academy of Sciences.
[47] F. Lang,et al. SGK, renal function and hypertension. , 2010, Journal of nephrology.
[48] T. Nakayama,et al. Association of HSD3B1 and HSD3B2 gene polymorphisms with essential hypertension, aldosterone level, and left ventricular structure. , 2010, European journal of endocrinology.
[49] T. Hansen,et al. Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population , 2010, Journal of internal medicine.
[50] Ian R. Holzman,et al. Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers. , 2009, The Journal of nutrition.
[51] W. Cefalu,et al. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice , 2009, Diabetes.
[52] A. Burlingame,et al. Keratin 20 Serine 13 Phosphorylation Is a Stress and Intestinal Goblet Cell Marker* , 2006, Journal of Biological Chemistry.
[53] S. Gray-Owen,et al. CEACAM1: contact-dependent control of immunity , 2006, Nature Reviews Immunology.
[54] K. Ranganna,et al. Butyrate inhibits proliferation-induced Proliferating Cell Nuclear Antigen expression (PCNA) in rat vascular smooth muscle cells , 2000, Molecular and Cellular Biochemistry.
[55] E. Levy,et al. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway , 2003, Gut.
[56] S. Oparil,et al. Sex hormones and hypertension. , 2002, Cardiovascular research.
[57] J. L. Napoli. 17β-Hydroxysteroid dehydrogenase type 9 and other short-chain dehydrogenases/reductases that catalyze retinoid, 17β- and 3α-hydroxysteroid metabolism , 2001, Molecular and Cellular Endocrinology.
[58] T. Tai,et al. Assessment of the function and effect of diabetes education programs in Taiwan. , 1999, Diabetes research and clinical practice.
[59] U. Smith,et al. Elevated fibrinogen and plasminogen activator inhibitor (PAI‐1) in hypertension are related to metabolic risk factors for cardiovascular disease , 1990, Journal of internal medicine.